M&A
Lilly to Buy Calytrix Bio for Up to $1.5 Billion
Eli Lilly & Co. agreed to buy Calytrix Bio Inc. for up to $1.5 billion in cash, extending one of the busiest acquisition runs…
Archive
Eli Lilly & Co. agreed to buy Calytrix Bio Inc. for up to $1.5 billion in cash, extending one of the busiest acquisition runs…